Jason Karlawish
14 Podcast Episodes
Is it time for geriatricians to get on board with lecanemab? Jason Karlawish and Ken Covinsky
Is it time for geriatricians to get on board with lecanemab? Jason Karlawish and Ken Covinsky
We’ve talked at length on prior podcasts about the failures of aducnumab, Biogen, and the FDA’s decision to approve it. ... Read more
15 Dec 2022
•
49mins
10/6/22 Dr. Jason Karlawish "The Problem of Alzheimer's"
10/6/22 Dr. Jason Karlawish "The Problem of Alzheimer's"
Dr. Jason Karlawish (the University of Pennsylvania) is the author of "The Problem of Alzheimer's: How Science, Culture,... Read more
6 Oct 2022
•
47mins
Similar People
Adam Marcus
Jack Price
Matt Cook
Rene Almeling
W. W. Norton
Edzard Ernst
Lucy van de Wiel
Bijal P. Trivedi
B. Stecher
Alberto Cairo
Douglas Fields
Randi Hutter Epstein
Peter Hotez
Phillipa Chong
Jenny Bangham
Conversations: Jason Karlawish, MD
Conversations: Jason Karlawish, MD
Alzheimer's disease used to be a rare diagnosis. But today, more than 5.8 million Americans are living with Alzheimer's ... Read more
2 Nov 2021
•
45mins
EP74 Catalyst: Dr Jason Karlawish on dementia and Alzheimers
EP74 Catalyst: Dr Jason Karlawish on dementia and Alzheimers
In this session Danielle Kelly, our Director of Culture & Inclusion at Herbert Smith Freehills joins leading expert ... Read more
14 Sep 2021
•
39mins
Most Popular
Elon Musk
Barack Obama
Bill Gates
LeBron James
Mark Cuban
Michelle Obama
Melinda Gates
Arnold Schwarzenegger
Kevin Hart
Terry Crews
Mike Tyson
EP74: Dr Jason Karlawish on dementia and Alzheimers
EP74: Dr Jason Karlawish on dementia and Alzheimers
In this session Danielle Kelly, our Director of Culture & Inclusion at Herbert Smith Freehills joins leading expert ... Read more
18 Aug 2021
•
39mins
Aducanumab (Aduhelm) for the Treatment of Alzheimers: A Podcast with Aaron Kesselheim and Jason Karlawish
Aducanumab (Aduhelm) for the Treatment of Alzheimers: A Podcast with Aaron Kesselheim and Jason Karlawish
On June 7th, 2021 FDA approved the amyloid beta-directed antibody aducanumab (Aduhelm) for the Treatment of Alzheimers. ... Read more
29 Jul 2021
•
44mins
Lockdown dementia with Jason Karlawish and Jennifer Watt
Lockdown dementia with Jason Karlawish and Jennifer Watt
The pandemic had a high mortality toll in care homes, but measures to try and reduce that, through extreme social isolat... Read more
15 Jul 2021
•
49mins
Jason Karlawish, "The Problem of Alzheimer's: How Science, Culture, and Politics Turned a Rare Disease into a Crisis and What We Can Do About It" (St. Martin's Press, 2021)
Jason Karlawish, "The Problem of Alzheimer's: How Science, Culture, and Politics Turned a Rare Disease into a Crisis and What We Can Do About It" (St. Martin's Press, 2021)
In 2020, an estimated 5.8 million Americans had Alzheimer’s, and more than half a million died because of the disease an... Read more
11 May 2021
•
1hr 4mins
Jason Karlawish, "The Problem of Alzheimer's: How Science, Culture, and Politics Turned a Rare Disease into a Crisis and What We Can Do About It" (St. Martin's Press, 2021)
Jason Karlawish, "The Problem of Alzheimer's: How Science, Culture, and Politics Turned a Rare Disease into a Crisis and What We Can Do About It" (St. Martin's Press, 2021)
In 2020, an estimated 5.8 million Americans had Alzheimer’s, and more than half a million died because of the disease an... Read more
11 May 2021
•
1hr 4mins
Jason Karlawish, "The Problem of Alzheimer's: How Science, Culture, and Politics Turned a Rare Disease into a Crisis and What We Can Do About It" (St. Martin's Press, 2021)
Jason Karlawish, "The Problem of Alzheimer's: How Science, Culture, and Politics Turned a Rare Disease into a Crisis and What We Can Do About It" (St. Martin's Press, 2021)
In 2020, an estimated 5.8 million Americans had Alzheimer’s, and more than half a million died because of the disease an... Read more
11 May 2021
•
1hr 4mins
